moxonidine has been researched along with Kidney Diseases in 3 studies
moxonidine: structure given in first source
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
Excerpt | Relevance | Reference |
---|---|---|
" The advantages of imidazoline receptors in neuroprotective of moxonidine in patients with arterial hypertension, metabolic syndrome, and diabetes mellitus is discussed in detail." | 8.93 | [Renoprotecion With Metabolic Syndrome: the Possibility of Receptor Agonist Imidazoline Moxonidine]. ( Ostroumova, OD; Zykova, AA, 2016) |
" The advantages of imidazoline receptors in neuroprotective of moxonidine in patients with arterial hypertension, metabolic syndrome, and diabetes mellitus is discussed in detail." | 4.93 | [Renoprotecion With Metabolic Syndrome: the Possibility of Receptor Agonist Imidazoline Moxonidine]. ( Ostroumova, OD; Zykova, AA, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ostroumova, OD | 1 |
Zykova, AA | 1 |
Tsutsui, H | 1 |
Sugiura, T | 1 |
Hayashi, K | 1 |
Ohkita, M | 1 |
Takaoka, M | 1 |
Yukimura, T | 1 |
Matsumura, Y | 1 |
Ernsberger, P | 1 |
Koletsky, RJ | 1 |
Friedman, JE | 1 |
1 review available for moxonidine and Kidney Diseases
Article | Year |
---|---|
[Renoprotecion With Metabolic Syndrome: the Possibility of Receptor Agonist Imidazoline Moxonidine].
Topics: Animals; Antihypertensive Agents; Humans; Hypertension; Imidazoles; Imidazoline Receptors; Kidney; K | 2016 |
2 other studies available for moxonidine and Kidney Diseases
Article | Year |
---|---|
Moxonidine prevents ischemia/reperfusion-induced renal injury in rats.
Topics: Adrenergic Agonists; Animals; Imidazoles; Imidazolines; Injections, Intravenous; Ischemia; Kidney; K | 2009 |
Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X.
Topics: Animals; Anti-Obesity Agents; Carrier Proteins; Disease Models, Animal; Endocrine System; Female; Hy | 1999 |